FDA warns consumers against using 26 over-the-counter artificial tear products due to infection risk which could lead to potential blindness. Products marketed
Chemotherapy drug shortages put young patients at risk; restrictions and challenges cause concerns of a rise in teen births; at least 28 companies failed to prove sufficient product testing for cough syrups.